Technology
Health
Pharmaceutical

Celyad

$21.87
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.27 (1.25%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Celyad and other stocks, options, ETFs, and crypto commission-free!

About

Celyad SA American Depositary Shares, also called Celyad, is a clinical-stage biopharmaceutical company, which engages in the identification and development of specialized cell-based therapies. Its products include cardiopoiesis platform, immuno-oncology, and medical devices. Read More The company was founded by Michel Lussier and William Wijns on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.

Employees
87
Headquarters
Mont-Saint-Guibert, Walloon Region
Founded
2007
Market Cap
257.95M
Price-Earnings Ratio
Dividend Yield
Average Volume
8.24K
High Today
$22.80
Low Today
$21.85
Open Price
$22.00
Volume
6.22K
52 Week High
$37.50
52 Week Low
$15.36

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
Medical Devices
2015 IPO
Europe (Non-UK)

Earnings

Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
Available Mar 29
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.